Bradley Block, MD
Otolaryngology · Garden City, NYNPI 1760620850
Payments from drug & device makers
Across 215 payments — averaging $43.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$6K
- Sanofi$987
- Regeneron Healthcare Solutions, Inc.$906
- GSK$738
- Optinose US, Inc.$344
- Inspire Medical Systems, Inc.$194
- plus $661 from 19 others
What the payments were for
- Consulting fees$4,25545%
- Travel & lodging$95310%
- Food & beverage$4,21445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 8 | $5,592 |
| Sanofi | 35 | $987 |
| Regeneron Healthcare Solutions, Inc. | 53 | $906 |
| GSK | 65 | $738 |
| Optinose US, Inc. | 17 | $344 |
| Inspire Medical Systems, Inc. | 5 | $194 |
| Grifols USA, LLC | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Novartis | 4 | $63 |
| Stryker | 1 | $58 |
| Kaleo, Inc. | 3 | $57 |
| Alk-abello, Inc | 3 | $38 |
| Merck | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $29 |
| Biocryst US Sales Co., LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Aerin Medical Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Intersect ENT, Inc. | 1 | $12 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,422 in reported general payments places this provider in the 85th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 91 | $1,766 |
| Fluticasone Propionate | 45 | $519 |
| Betamethasone Dipropionate | 13 | $265 |
| Mometasone Furoate | 20 | $182 |
| Doxycycline Monohydrate | 24 | $163 |
| Mupirocin | 15 | $128 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $118 |
| Prednisone | 37 | $75 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Garden City
- Robert KellmanSyracuse$2.5M
- Anthony DelsignoreNew York$966K
- Roheen RaithathaNew York$882K
- Dennis KrausNew York$524K
- Ashutosh KackerNew York$387K
- Lawrence LustigNew York$383K
- Brett MilesNew York$368K
- Alfred Marc IloretaNew York$342K
- Nora PerkinsAlbany$315K
- Gavin SetzenAlbany$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.